Flowers Foods, Inc. Reports Second Quarter 2026 Results

Flowers Foods posts sharp profit drop and lowers 2026 outlook amid falling sales.

What the company is saying

Flowers Foods, Inc. reports a 4.0% decline in net sales to $1.193 billion for the second quarter of 2026 and a 30.3% drop in net income to $40.7 million. Management frames the downturn as a catalyst for accelerating cost structure improvements, sharpening the value proposition, and investing in leading brands. The company emphasizes ongoing initiatives to realign operations and respond to evolving consumer needs, while updating its full-year outlook to reflect a more cautious stance. The tone is candid and acknowledges the negative trajectory, with CEO Ryals McMullian directly addressing the need for operational changes. The announcement highlights the company's confidence in long-term brand leadership but provides limited detail on specific turnaround actions. Forward-looking statements are measured and do not attempt to minimize the scale of the current deterioration.

What the data suggests

Net sales fell 4.0% to $1.193 billion in the quarter, with branded retail sales down 3.8% and other net sales down 4.4%. Net income dropped 30.3% to $40.7 million, representing just 3.4% of sales, and adjusted net income declined 30.5% to $44.1 million. Adjusted EBITDA decreased 19.2% to $111.3 million, with margin falling 180 basis points to 9.3% of sales. Diluted EPS fell by $0.09 to $0.19, and adjusted diluted EPS dropped to $0.21. Operating cash flow year-to-date decreased $24.9 million to $241.5 million, while capital expenditures and dividends paid also declined. The updated 2026 outlook projects net sales of $5.070–$5.142 billion, adjusted EBITDA of $453–$481 million, and adjusted diluted EPS of $0.75–$0.85 per share—all lower than prior guidance. Disclosures are detailed for current period figures and percentage changes, but lack prior period base numbers for full verification. The overall financial trajectory is negative, with no evidence of stabilization yet.

Analysis

The announcement is factual and direct, with the majority of claims focused on realised, backward-looking financial results that are negative: net sales, net income, adjusted EBITDA, and EPS all declined materially. The only forward-looking statements are the updated full-year outlook and management's commentary on ongoing initiatives, but these are presented cautiously and reflect a more conservative view for the remainder of the year. There is no attempt to inflate the narrative or overstate progress; the language is measured and acknowledges the deterioration in performance. Capital expenditures are disclosed but are not paired with promises of near-term transformative returns, and the scale is not outsized relative to the company's operations. The gap between narrative and evidence is minimal, and there are no exaggerated claims.

Risk flags

• ●Sustained volume declines in both branded retail and store-branded sales signal ongoing demand weakness, raising the risk that cost initiatives may not be sufficient to stabilize revenues in the near term. The 5.8% consolidated volume decline and 7.6% drop in branded retail volume underscore the challenge.
• ●Profitability deterioration is pronounced, with net income margin dropping 130 basis points and adjusted EBITDA margin falling 180 basis points. This margin compression, coupled with higher materials and SD&A costs as a percentage of sales, suggests operational leverage is negative and cost control may not offset revenue headwinds.
• ●Guidance has been revised downward for all major metrics—net sales, adjusted EBITDA, and adjusted diluted EPS—indicating management does not expect a quick recovery. The lack of granular detail on the drivers of underperformance and the specifics of planned cost actions limits visibility into the path to improvement.
• ●Cash flow from operations, capital expenditures, and dividends paid have all decreased year-to-date, which may constrain the company’s flexibility to invest in growth or maintain shareholder returns if the negative trend persists. The cash and cash equivalents balance of $52.8 million is modest relative to the scale of operations.

Bottom line

Flowers Foods is experiencing a broad-based deterioration in financial performance, with falling sales, sharply lower profits, and compressed margins across its business lines. The company’s updated 2026 guidance confirms that management expects these headwinds to persist, and there is no evidence in the disclosure of a near-term turnaround. While management is candid about the challenges and outlines a focus on cost structure and brand investment, the absence of specific, measurable milestones or quantified benefits from these initiatives makes the recovery timeline uncertain. The disclosure is adequate for trend analysis but lacks the transparency needed for rigorous verification of the claimed declines. Investors should view this announcement as a clear negative, with the most important takeaway being the company’s admission that both revenue and profitability are under pressure with no short-term fix in sight. Further detail on the execution and impact of cost and operational initiatives would be required to reassess the risk profile.

Announcement summary

(NYSE: FLO) Flowers Foods, Inc. reported that net sales for the 12-week second quarter ended July 18, 2026, decreased 4.0% to $1.193 billion. Net income decreased 30.3% to $40.7 million, representing 3.4% of sales, a 130-basis point decrease. Adjusted net income decreased 30.5% to $44.1 million. Adjusted EBITDA decreased 19.2% to $111.3 million, representing 9.3% of net sales, a 180-basis point decrease. Diluted EPS decreased $0.09 to $0.19, and adjusted diluted EPS decreased $0.09 to $0.21. The company updated its full-year outlook, expecting net sales of approximately $5.070 billion to $5.142 billion, adjusted EBITDA in the range of approximately $453 million to $481 million, and adjusted diluted EPS of approximately $0.75 to $0.85 per share. Cash flow from operating activities year-to-date decreased $24.9 million to $241.5 million, capital expenditures decreased $11.9 million to $44.5 million, and dividends paid to shareholders decreased $23.7 million to $81.0 million.

Disagree with this article?